As of 2025-12-14, the Relative Valuation of Edgewise Therapeutics Inc (EWTX) is (28.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.62 USD, the upside of Edgewise Therapeutics Inc based on Relative Valuation is -220.6%.
The range of the Relative Valuation is (28.55) - (29.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 19.8x | 18.7x |
| Forward P/E multiples | 19.2x - 20.1x | 19.6x |
| Fair Price | (28.55) - (29.44) | (28.48) |
| Upside | -220.9% - -224.6% | -220.6% |
| Date | P/E |
| 2025-12-05 | -15.88 |
| 2025-12-04 | -15.96 |
| 2025-12-03 | -15.70 |
| 2025-12-02 | -15.47 |
| 2025-12-01 | -17.01 |
| 2025-11-28 | -17.53 |
| 2025-11-26 | -17.18 |
| 2025-11-25 | -16.20 |
| 2025-11-24 | -15.81 |
| 2025-11-21 | -15.26 |
| 2025-11-20 | -14.98 |
| 2025-11-19 | -15.04 |
| 2025-11-18 | -14.92 |
| 2025-11-17 | -14.99 |
| 2025-11-14 | -15.32 |
| 2025-11-13 | -13.75 |
| 2025-11-12 | -14.25 |
| 2025-11-11 | -14.46 |
| 2025-11-10 | -12.31 |
| 2025-11-07 | -11.55 |
| 2025-11-06 | -11.51 |
| 2025-11-05 | -11.70 |
| 2025-11-04 | -11.66 |
| 2025-11-03 | -12.10 |
| 2025-10-31 | -12.31 |
| 2025-10-30 | -12.57 |
| 2025-10-29 | -10.99 |
| 2025-10-28 | -11.06 |
| 2025-10-27 | -10.79 |
| 2025-10-24 | -10.22 |
| 2025-10-23 | -10.17 |
| 2025-10-22 | -10.03 |
| 2025-10-21 | -10.44 |
| 2025-10-20 | -10.36 |
| 2025-10-17 | -10.14 |
| 2025-10-16 | -10.31 |
| 2025-10-15 | -10.52 |
| 2025-10-14 | -9.90 |
| 2025-10-13 | -9.90 |
| 2025-10-10 | -10.17 |
| 2025-10-09 | -10.81 |
| 2025-10-08 | -10.34 |
| 2025-10-07 | -10.19 |
| 2025-10-06 | -10.34 |
| 2025-10-03 | -10.54 |
| 2025-10-02 | -10.10 |
| 2025-10-01 | -10.40 |
| 2025-09-30 | -10.92 |
| 2025-09-29 | -10.60 |
| 2025-09-26 | -10.81 |